Literature DB >> 2064418

Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.

A C Halpern1, D Guerry, D E Elder, W H Clark, M Synnestvedt, S Norman, R Ayerle.   

Abstract

The melanoma risk associated with dysplastic nevi outside the context of familial melanoma was studied by the case-control method. One hundred five newly diagnosed incident melanoma cases with negative family histories for familial melanoma and 181 controls (frequency matched for race, age, and sex) were studied by personal interview and cutaneous examination. The prevalence of dysplastic nevi was 41 (39%) of 105 in the cases and 13 (7%) of 181 in the controls. The odds ratio for dysplastic nevi by multiple logistic regression analysis simultaneously correcting for age, sex, eye color, hair color, actinic damage, freckles, and total number of nondysplastic nevi was 6.8 (95% confidence interval, 2.7, 16.9). This study supports the significance of dysplastic nevi as markers of increased risk for nonfamilial melanoma.

Entities:  

Mesh:

Year:  1991        PMID: 2064418

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  11 in total

1.  Cigarette smoking and malignant melanoma: a case-control study.

Authors:  Maria C Kessides; Lee Wheless; Judith Hoffman-Bolton; Sandra Clipp; Rhoda M Alani; Anthony J Alberg
Journal:  J Am Acad Dermatol       Date:  2010-03-23       Impact factor: 11.527

2.  The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects.

Authors:  Keith Duffy; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2012-07       Impact factor: 11.527

3.  DNA repair synthesis following irradiation with 254-nm and 312-nm ultraviolet light is not diminished in fibroblasts from patients with dysplastic nevus syndrome.

Authors:  H W Thielmann; O Popanda; L Edler; A Böing; E G Jung
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

4.  Risk factors for growth and metastasis of small choroidal melanocytic lesions.

Authors:  C L Shields; J A Shields; H Kiratli; P De Potter; J R Cater
Journal:  Trans Am Ophthalmol Soc       Date:  1995

Review 5.  Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.

Authors:  M R Hussein
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

6.  Prepubertal melanoma in a medium-sized congenital naevus.

Authors:  L De Raeve; W Danau; A De Backer; J Otten
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

Review 7.  Familial melanoma: a complex disorder leading to controversy on DNA testing.

Authors:  Femke A de Snoo; Wilma Bergman; Nelleke A Gruis
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

Review 8.  Melanoma risk factors and atypical moles.

Authors:  M L Williams; R W Sagebiel
Journal:  West J Med       Date:  1994-04

9.  Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study.

Authors:  V Bataille; J A Bishop; P Sasieni; A J Swerdlow; E Pinney; K Griffiths; J Cuzick
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

Review 10.  Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of CDKN2A Pathogenic Variants.

Authors:  Kristen Pauley; Ambreen Khan; Wendy Kohlmann; Joanne Jeter
Journal:  Front Oncol       Date:  2022-03-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.